Clinical Trial Informed Consent Affidavit

Clinical trials are the cornerstone of medical advancement, but they require meticulous documentation to protect both participants and researchers. A Clinical Trial Informed Consent Affidavit is essential for research institutions, pharmaceutical companies, hospitals, and academic medical centers conducting human subject research.

This comprehensive template helps research teams obtain legally compliant informed consent from clinical trial participants. The form covers all critical elements required by institutional review boards (IRBs), including detailed study information, potential risks and benefits, privacy protections under HIPAA, voluntary participation rights, and withdrawal procedures.

Paperform makes it simple to collect, store, and manage sensitive clinical trial consent documentation. With SOC 2 Type II compliance and robust security features, you can trust that participant information remains protected throughout the research process. The form's conditional logic ensures participants receive relevant information based on their specific circumstances, while calculation fields can help assess eligibility criteria automatically.

Use Papersign (papersign.com) to capture legally binding electronic signatures from participants, legally authorized representatives, and witnesses—creating a complete audit trail for regulatory compliance. Once consent is obtained, Stepper (stepper.io) can automate your research workflow by notifying study coordinators, updating participant databases, scheduling follow-up visits, and ensuring all required documentation is filed appropriately.

Whether you're running Phase I safety trials, Phase III efficacy studies, or observational research, this template provides the foundation for ethical, compliant participant enrollment. The professional design maintains the gravity and formality required for legal medical documentation while ensuring participants can clearly understand their rights and the study details before making an informed decision.